Abstract

BackgroundDengue viruses (DENV) are the causative agents of dengue, the world’s most prevalent arthropod-borne disease with around 40% of the world’s population at risk of infection annually. Wolbachia pipientis, an obligate intracellular bacterium, is being developed as a biocontrol strategy against dengue because it limits replication of the virus in the mosquito. The Wolbachia strain wMel, which has been introduced into the mosquito vector, Aedes aegypti, has been shown to invade and spread to near fixation in field releases. Standard measures of Wolbachia’s efficacy for blocking virus replication focus on the detection and quantification of virus in mosquito tissues. Examining the saliva provides a more accurate measure of transmission potential and can reveal the extrinsic incubation period (EIP), that is, the time it takes virus to arrive in the saliva following the consumption of DENV viremic blood. EIP is a key determinant of a mosquito’s ability to transmit DENVs, as the earlier the virus appears in the saliva the more opportunities the mosquito will have to infect humans on subsequent bites.Methodology/Principal FindingsWe used a non-destructive assay to repeatedly quantify DENV in saliva from wMel-infected and Wolbachia-free wild-type control mosquitoes following the consumption of a DENV-infected blood meal. We show that wMel lengthens the EIP, reduces the frequency at which the virus is expectorated and decreases the dengue copy number in mosquito saliva as compared to wild-type mosquitoes. These observations can at least be partially explained by an overall reduction in saliva produced by wMel mosquitoes. More generally, we found that the concentration of DENV in a blood meal is a determinant of the length of EIP, saliva virus titer and mosquito survival.Conclusions/SignificanceThe saliva-based traits reported here offer more disease-relevant measures of Wolbachia’s effects on the vector and the virus. The lengthening of EIP highlights another means, in addition to the reduction of infection frequencies and DENV titers in mosquitoes, by which Wolbachia should operate to reduce DENV transmission in the field.

Highlights

  • Dengue fever is caused by an RNA virus belonging to the genus Flavivirus and is primarily vectored by the mosquito Aedes aegypti

  • To test whether limited dengue replication in wMel mosquitoes translates to a reduction in dengue transmission potential, we used a non-destructive assay to repeatedly quantify dengue virus in mosquito saliva

  • We found that wMel significantly delayed the time it took for mosquito saliva to become infectious, reduced the frequency of dengue virus that was expectorated by mosquitoes and lowered the virus titer in mosquito saliva

Read more

Summary

Introduction

Dengue fever is caused by an RNA virus belonging to the genus Flavivirus and is primarily vectored by the mosquito Aedes aegypti. In laboratory-reared strains of wMel infected mosquitoes captured from field release regions, this antiviral activity, as measured by reduced infectivity of mosquitoes and reduced viral titers in tissues, remained strong even one year after field deployment [25]. This evidence bodes well for the long-term stability of the Wolbachia-based biocontrol effect against DENV. What remains is to test the ability of Wolbachia-infected mosquitoes to reduce transmission of human disease in a dengue endemic region Such trials are currently underway in Vietnam and Indonesia [9]. EIP is a key determinant of a mosquito’s ability to transmit DENVs, as the earlier the virus appears in the saliva the more opportunities the mosquito will have to infect humans on subsequent bites

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call